As we approach 2020, we take a few moments to look back at some of the biggest stories of the current year. Each year is extremely busy, and 2019 was no exception. Below we discuss some of the most popular topics of the year. How did we determine popularity? Simple…we decided to focus on the topics that generated the most questions.
Tag: Baqsimi
Post
FDA approves Eli Lilly’s Baqsimi, the first treatment for severe hypoglycemia that can be administered without an injection
In this week's post we discuss the approval of Baqsimi nasal powder. This is the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection.